U.S. Markets open in 4 hrs 17 mins


NasdaqCM . Currency in USD
Add to watchlist
People also watch
Full screen
Previous CloseN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals5 months ago

    Colorado biotech cutting employees, exploring 'strategic alternatives'

    In September , Venaxis Inc., a Castle Rock medical device company, acquired Bioptix Diagnostics Inc. of Boulder and renamed itself Bioptix Inc. T hat acquisition quickly turned nasty with a major shareholder accusing company executives of "an inside management job," with executives firing back at the shareholder. And earlier this month after the 2016 drama, Bioptix shook up its board and said three of its board members are leaving, including the former lieutenant governor of Colorado.

  • Venaxis, Inc. :APPY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
    Capital Cube7 months ago

    Venaxis, Inc. :APPY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016

    Categories: Yahoo Finance Get free summary analysis Venaxis, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Venaxis, Inc. – Vermillion, Inc., Chembio Diagnostics, Inc., OraSure Technologies, Inc., Alere Inc., Echo Therapeutics, Inc., American Bio Medica Corporation and Myriad Genetics, Inc. (VRML-US, CEMI-US, OSUR-US, ALR-US, ECTE-US, ... Read more (Read more...)

  • TheStreet.com10 months ago

    7 Stocks Under $10 Making Big Up Moves

    When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.